17 May 2023
RNZ's Kathryn Ryan talks to our Clinical Director Dr Rob Weinkove about our CAR T-cell clinical trial, what a recent commercial deal with global pharmaceutical Dr. Reddy's means and his ambition to see this become a mainstream treatment.
![](/assets/Uploads/Rob-W__FocusFillWyIwLjA2IiwiLTAuMzUiLDEwMCw0NV0.jpeg)
Related articles
![Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy](/assets/Uploads/ENABLE-2-team__FocusFillWyIwLjAzIiwiLTAuMjgiLDY4MCw0NDVd.jpg)
Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy
23 July 2024
Read more
![RNZ Our Changing World: Targeting bacteria, and health inequities](/assets/Uploads/Images/General/Tom-M-Sciencelens_MG_6532-v2__FocusFillWyIwLjAwIiwiMC4wMCIsNjgwLDQ0NV0.jpg)
RNZ Our Changing World: Targeting bacteria, and health inequities
4 July 2024
Read more
![New clinical research aims to reduce stomach cancer rates and disparities in New Zealand](/assets/Uploads/Tom-M-Sciencelens_MG_6532-1__FocusFillWyItMC4wNiIsIi0wLjQwIiw2ODAsNDQ1XQ.jpg)
New clinical research aims to reduce stomach cancer rates and disparities in New Zealand
28 May 2024
Read more
![A revolution in cancer care is near; here’s what’s needed to make it happen](/assets/Uploads/Images/General/GLG-Labshot-1__FocusFillWyIwLjAwIiwiMC4wMCIsNjgwLDQ0NV0.jpg)
A revolution in cancer care is near; here’s what’s needed to make it happen
9 May 2024
Read more
![Significant milestone reached in first NZ CAR T-cell trial as preparations made for larger phase 2 registration trial](/assets/Uploads/Images/General/IMG_0446__FocusFillWyIwLjAwIiwiMC4wMCIsNjgwLDQ0NV0.jpg)
Significant milestone reached in first NZ CAR T-cell trial as preparations made for larger phase 2 registration trial
25 March 2024
Read more
![RNZ: Engineering immune cells to kill cancer](/assets/Uploads/4L04KD5_cancer_collage_jpg__FocusFillWyIwLjAyIiwiLTAuMzIiLDY4MCw0NDVd.jpeg)
RNZ: Engineering immune cells to kill cancer
5 November 2023
Read more